Johnson & Johnson

13F Holdings History for Rapport Therapeutics, Inc. - Common Stock, $0.001 par value (RAPP)

Symbol: RAPP on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 1.78M shares
Security Ownership: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

JOHNSON & JOHNSON ownership in Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP)

2025-10-22 - JOHNSON & JOHNSON has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.78M shares of Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP). This represents 4.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JOHNSON & JOHNSON	4.9%		$53M	1.78M			$29.70	13G/A	9/30/2025	22 Oct 2025 17:09:06

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	8.55%		$28.6M	2.5M			$11.43	Q2 2025
3/31/2025	7.33%		$25.1M	2.5M			$10.03	Q1 2025
12/31/2024	11.5%		$44.3M	2.5M			$17.74	Q4 2024
9/30/2024	12%		$51.2M	2.5M			$20.48	Q3 2024
6/30/2024	14.5%	+1.32%	$58.1M	2.5M	+2,498,051	NEW	$23.26	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.